RxDoctor Payments DataLook up a doctor →

Mitchell Feinman

Rheumatology · Orangeburg, SCNPI 1841479623

Payments from drug & device makers

$824,497in general payments, 2019–2025

Across 550 payments — averaging $1499.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$428K
  • Gilead$210K
  • UCB SA$65K
  • E.r. Squibb & Sons, L.L.C.$55K
  • Amgen$30K
  • Pfizer$29K
  • plus $8K from 22 others
$1,972in research payments, 2019–2025

Across 10 payments — averaging $197.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$2K

What the payments were for

  • Speaking & faculty fees$18,89064%
  • Travel & lodging$2,7349%
  • Food & beverage$7,98427%
  • Education$30%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$824,497 in reported general payments places this provider in the 90th percentile of 123 rheumatology providers in South Carolina.

See all rheumatology providers in South Carolina

Other rheumatology in Orangeburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →